Presentation
11 March 2020 Quantitative phase digital holographic microscopy combined with stem cell technology for identifying cell biomarkers of neurodevelopmental brain disorders including schizophrenia (Conference Presentation)
Author Affiliations +
Proceedings Volume 11249, Quantitative Phase Imaging VI; 112490V (2020) https://doi.org/10.1117/12.2546407
Event: SPIE BiOS, 2020, San Francisco, California, United States
Abstract
The recent developments in stem cell biology especially the generation of induced pluripotent stem cells (iPSCs) has made possible the development of in vitro cellular models of developmental brain disorders including schizophrenia. Within this framework, we will present how quantitative phase imaging and in particular quantitative phase digital holographic microscopy (QP-DHM), as a label-free technique is able to study these in vitro cellular models and identify both some pathophysiological processes and cell biomarkers related to developmental brain disorders. This will be illustrated by the exploration with QP-DHM of human neuronal networks derived from iPSCs coming from patients suffering from schizophrenia.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Pierre P. Marquet, François Paquet-Mercier, Chloé Martel, Catherine Giroux, Carine Ben Adiba, Ana-Sofia Correia, Émile Rioux Pellerin, Jean-Xavier Giroux, Marie-Eve Crochetière, Erik Bélanger, and Pascal Jourdain "Quantitative phase digital holographic microscopy combined with stem cell technology for identifying cell biomarkers of neurodevelopmental brain disorders including schizophrenia (Conference Presentation)", Proc. SPIE 11249, Quantitative Phase Imaging VI, 112490V (11 March 2020); https://doi.org/10.1117/12.2546407
Advertisement
Advertisement
KEYWORDS
Digital holography

Brain

Holography

Microscopy

Stem cells

In vitro testing

Water

Back to Top